Whereas nicotinamide riboside (NAMR) is equally effective in increasing levels of NAD+(P+) as nicotinamide, it is 3-fold more active in increasing the ADP-ribose product of the PARP and SIRT reactions [155], an undesirable effect as PARPs are already activated by COVID-19. Here, PARP1 is linked to COVID-19.